What are the anesthesia considerations for a patient on hydroxychloroquine (Plaquenil)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Anesthesia Considerations for Plaquenil (Hydroxychloroquine)

The primary anesthesia concern for patients on hydroxychloroquine is QT interval prolongation and the risk of serious cardiac arrhythmias, particularly when combined with other QT-prolonging drugs commonly used perioperatively.

Cardiac Monitoring and Drug Interactions

Mandatory ECG monitoring is essential throughout the perioperative period for patients on hydroxychloroquine 1. Hydroxychloroquine causes multiple cardiac adverse events, with significant QT prolongation being the most critical concern 1.

High-Risk Drug Combinations

Avoid or use extreme caution when combining hydroxychloroquine with:

  • Halogenated anesthetics (sevoflurane, desflurane) - risk of cardiac toxicity 1
  • Droperidol - additive/synergistic QT prolongation 1
  • Ondansetron - additive QT prolongation 1
  • Azithromycin - particularly dangerous combination with additive/synergistic QT prolongation 1
  • Dexmedetomidine - risk of cardiac toxicity 1
  • Haloperidol - risk of cardiac toxicity 1
  • Tramadol - risk of cardiac toxicity 1

Environmental Factors

Hypothermia related to surgery and anesthesia may increase the risk of developing ventricular fibrillation in patients on hydroxychloroquine 1. Maintain normothermia aggressively throughout the perioperative period.

Safe Anesthetic Drug Choices

According to drug interaction data, hydroxychloroquine shows no significant interactions with 1:

  • Remifentanil
  • Cisatracurium
  • Paracetamol (acetaminophen)
  • Diclofenac
  • Ibuprofen
  • Heparin
  • Oxazepam
  • Most local anesthetics (bupivacaine, lidocaine)
  • Propofol (though monitor for potential cardiac effects)
  • Ketamine
  • Fentanyl
  • Morphine

Preoperative Assessment

Cardiac Evaluation

  • Obtain baseline ECG focusing on QT interval measurement 2
  • Review for pre-existing cardiac conduction abnormalities
  • Document any history of cardiomyopathy (prolonged hydroxychloroquine therapy can cause toxic cardiomyopathy) 2

Neuromuscular Assessment

  • Assess for proximal muscle weakness (hydroxychloroquine can cause toxic myopathy) 3
  • Evaluate for peripheral neuropathy 3
  • These toxicities are more common with concurrent renal failure 3

Renal Function

  • Check renal function carefully - renal impairment increases risk of hydroxychloroquine toxicity 3
  • Consider dose adjustments of renally cleared anesthetic drugs

Dosing Verification

  • Confirm hydroxychloroquine dose is ≤5.0 mg/kg/day actual body weight (or ≤400 mg/day) 4, 5
  • Higher doses significantly increase toxicity risk 4

Intraoperative Management

Monitoring Requirements

  • Continuous ECG monitoring with QT interval assessment 1
  • Standard ASA monitors (SpO2, NIBP, capnography) 6
  • Consider processed EEG monitoring if using TIVA with neuromuscular blockade 6
  • Maintain normothermia with active warming 1

Anesthetic Technique Selection

Regional anesthesia should be prioritized whenever feasible 1 to:

  • Minimize exposure to potentially interacting systemic drugs
  • Reduce cardiac stress
  • Avoid QT-prolonging volatile anesthetics

If general anesthesia is required:

  • Use remifentanil-based TIVA as first choice (no interaction) 1
  • If using volatile agents, monitor carefully for arrhythmias 1
  • Avoid droperidol and ondansetron for PONV prophylaxis 1

Common Pitfalls to Avoid

  1. Do not assume hydroxychloroquine is benign - it has significant cardiac toxicity potential 1, 2
  2. Do not combine multiple QT-prolonging drugs without careful risk-benefit assessment 1
  3. Do not overlook renal function - this dramatically increases toxicity risk 3
  4. Do not forget to maintain normothermia - hypothermia compounds arrhythmia risk 1
  5. Do not discontinue hydroxychloroquine perioperatively unless specifically indicated - sudden discontinuation may worsen underlying disease 2

Special Populations

Patients with Lupus or Rheumatoid Arthritis

  • Continue hydroxychloroquine through the perioperative period 2
  • Coordinate with rheumatology regarding corticosteroid coverage if applicable
  • These patients may be on multiple immunosuppressants - check all drug interactions

Pregnancy

Hydroxychloroquine is considered safe during pregnancy (Pregnancy Category C) 2, but standard obstetric anesthesia precautions apply with heightened cardiac monitoring.

Emergency Considerations

In case of suspected hydroxychloroquine toxicity (rare but potentially fatal):

  • Symptoms include cardiovascular collapse, bradycardia, arrhythmias, convulsions, hypoventilation 5, 7
  • Diazepam administered parenterally may reverse cardiotoxicity 5
  • Provide respiratory support and vasopressor therapy as needed 5, 7
  • Consider dopamine, noradrenaline, or adrenaline for cardiovascular depression 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.